| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2025 , Vol 63 , Num 2
Development and in vitro characterization studies of novel chitosan nanoparticles for the treatment of Huntington's disease
1 University of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Biotechnology, Istanbul, Türkiye, 2 Istanbul University-Cerrahpasa, Faculty of Engineering, Department of Chemical Engineering, Istanbul, Türkiye, 3 University of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Technology, Istanbul, Türkiye, 4 Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Istanbul, Türkiye
DOI :
10.23893/1307-2080.APS6316